Clinical study on Abhraloha in iron deficiency Anemia

INTERVENTION: Intervention1: Abhraloha: Proprietary medicine indicated in Pandu. It consists of Loha Bhasma, Abhraka Bhasma, Amalaki, Shatavari etc.Total duration of therapy is 2 months Control Intervention1: Ferrous Ascorbate: Tab. Ferrous ascorbate 100 mg equivalent to 100 mg elemental iron & Folic Acid 1.5 mg Tablets two times a day is standard of care for iron deficiency anemia marketed iron preparation.The duration of therapy is 2 months. CONDITION: Iron deficiency anemia, unspecified PRIMARY OUTCOME: ï?? To evaluate efficacy of Abhraloha in patients suffering from Iron deficiency anemia by assessing change in Haemoglobin level from baseline to the 8 week or at the final visit at the time of subject discontinuation.Timepoint: Day 0, Day 14, Day 28, Day 56 SECONDARY OUTCOME: 1. serum ferritin, ; 2. Iron profile ; 3. red cell indices ; assessing change from baseline to final visit at the time of subject discontinuation visit. ; 4. improvement of signs of Pandurog assessed according to Ayurveda ; 5. symptomatic improvement in patient using fatigue scale. ; 6. safety of drug on clinical and laboratory parameters.Timepoint: Day 0, Day 14, Day 28, Day 56 INCLUSION CRITERIA: 1. Women >18 years to <65 years old. 2. Women diagnosed with iron deficiency anemia (criteria stated in Annexure 1) and Hbâ?¤10 g/dL and >7gm/dl and serum ferritin <30ug/L 3. Women in postpartum period 10 days after delivery 4. Women with negative urine pregnancy test.